Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

May 3, 2021

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
InnoSer is at AACR with its Oncology Offerings

InnoSer is at AACR with its Oncology Offerings

Apr 7, 2021

Innoser is putting oncology development at the forefront of our efforts this year. By attending this year’s AACR 2021, we hope to improve our innovative oncology offerings and learn from the best. This year the American Association for Cancer Research is hosting...
BlastomaBrain: New in vitro platform for oncology drug development

BlastomaBrain: New in vitro platform for oncology drug development

Feb 23, 2021

One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...
InnoSer offers new in vivo imaging capabilities

InnoSer offers new in vivo imaging capabilities

Nov 20, 2020

InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...